VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer
VahatiCor, Inc., a medtech company developing interventional therapies for Coronary Microvascular Dysfunction (CMD), announced today the appointment of Harry D. Rowland, Ph.D., as Chief Executive Officer.
